£849

European medical cannabis market sizing forecasts (2023-2027) for 29 European countries, including: Germany, UK, France, Italy, Poland, Switzerland, Spain, Croatia, Austria, Luxembourg, Sweden, Netherlands, Malta, Belgium, Denmark, Czech Republic, Greece, Portugal, Romania, North Macedonia, Finland, Slovakia, Lithuania, Cyprus, Slovenia, Norway, Albania, Latvia, Estonia & Ireland. This package also includes patient population forecasts for each of the aforementioned countries.

Our model estimates the eligible population for getting medical cannabis based on disease prevalence data for the countries in question. The penetration rate among this population is calculated from existing data on patient numbers, prescriptions and distribution of related medicines. The model combines this number with data and estimates for prices and dosages and produces the final sizing of the market.

This data is formatted in an Excel spreadsheet (.xls) and will be sent to you digitally via email.